Skip to main content

Table 3 Clustering of 38 DEGs according to the expression profiles of 16 patients with serous ovarian cancer; Up-regulation corresponds to log2 ratio > threshold while down-regulation to log2 ratio < minus value of threshold.

From: Identification of differentially expressed genes using an annealing control primer system in stage III serous ovarian carcinoma

Threshold Group 1 Group 2 Group 3 Group 4
  up-regulated down-regulated up-regulated down-regulated up-regulated down-regulated up-regulated down-regulated
0.5 88.9% 6.9% 68.8% 15.6% 63.9% 22.2% 19.4% 68.8%
1.0 86.8% 5.6% 58.8% 12.5% 55.6% 18.1% 9.3% 60.3%
1.5 84.0% 4.2% 45.6% 7.5% 48.6% 13.2% 6.3% 46.3%
2.0 77.1% 3.5% 31.9% 6.9% 41.0% 11.8% 3.1% 33.1%
Accession no. (gene symbol) NM_003143.1 (SSBP1) AY871274 (RPL11) NM_001867 (COX7C) BC013003 (ANP32B) AK302766 (RBM5) NM_032682 (FOXP1)
  NM_022873.2 (IFI6) BC000523 (RPS24) BC013003 (ANP32B) NM_032682 (FOXP1)
  NM_001355.3 (DDT) BC012823 NM_000978 (RPL23) NG_001229 (NUDCP2)
  NM_005532(IFI27) NM_001101654(CXXC1) NM_013974.1 (DDAH2) AK025219
  NM_207429.2 (C11orf92) NM_001034996(RPL14) XM_002345433 BC001120 (LGALS3) NM_032508.1 (TMEM185A)
  NM_020529(NFKBIA) NM_001037637(BTF3) BC107854 (ATP6V1F)  
  NM_032470(TNXB) NM_001020(RPS16) NM_001004333.3 (RNASEK) NM_002292.3 (LAMB2)
  EF177379 (NEAT1) NR_003225(LGALS3) NM_080390(TCEAL2) AK293439 (XRCC6)
  BC02359 (TFG) NM_013318(BAT2L1) AK026649 NM_001100167(MRVI1) NM_001131005(MEF2C) NM_201442 (C1S)
  1. The percentage of up- and down-regulation was calculated for each group.